Us Bancorp \De\ Vera Therapeutics, Inc. Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 5 shares of VERA stock, worth $179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5Holding current value
$179% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
189Shares Held
56MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$155 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$141 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$120 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$106 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$100 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $970M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...